Home › Funds › DAVENPORT & Co LLC › ELV

DAVENPORT & Co LLC position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

DAVENPORT & Co LLC reported holding 384,435 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$150.0M, representing 0.95% of its reported portfolio and ranking #19 among its reported holdings. DAVENPORT & Co LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)384.44K sh
Reported value held$149.99M
Portfolio Weight0.95%
First reportedQ3 2023
Last changeReduce
Updated2026-10-14

Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR

How DAVENPORT & Co LLC's ELV position evolved

DAVENPORT & Co LLC first disclosed a stake in ELV in Q3 2023 at 250,073 shares (US$109.6M). The position peaked in Q3 2025 at 630,203 shares, worth US$203.0M. Across 13 filings, DAVENPORT & Co LLC increased the stake 3 time(s), trimmed it 6 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 384,435 shares valued at US$150.0M — a reduction of -57,505 shares quarter over quarter.. Notable position changes include a 128% increase in Q3 2025 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 250.07K $109.58M New
Q4 2023 248.96K $117.23M Hold
Q1 2024 244.57K $126.90M Reduce
Q2 2024 243.40K $131.55M Hold
Q3 2024 183.56K $95.60M Reduce
Q4 2024 228.06K $84.13M Add
Q1 2025 281.87K $122.42M Add
Q2 2025 276.45K $107.06M Reduce
Q3 2025 630.20K $203.05M Add
Q4 2025 575.78K $201.55M Reduce
Q1 2026 574.01K $166.76M Hold
Q2 2026 441.94K $171.10M Reduce
Q3 2026 384.44K $149.99M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has DAVENPORT & Co LLC held ELV?

DAVENPORT & Co LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is DAVENPORT & Co LLC's current position in ELV?

As of Q3 2026, DAVENPORT & Co LLC holds 384.44K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $149.99M, representing 0.95% of its reported portfolio and ranking #19.

Has DAVENPORT & Co LLC been buying or selling ELV?

In the latest 13F filing (Q3 2026), DAVENPORT & Co LLC reduced its position in ELV. The position peaked in Q3 2025 at 630.20K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.